Altus Pharmaceuticals
Altus Pharmaceuticals Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock
Published in Health Business Week, May 11th, 2007
Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced today the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $14.75 per share. Altus Pharmaceuticals has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any. All of the shares are being offered by Altus Pharmaceuticals. Merrill Lynch & Co. and Morgan Stanley & Co. are joint book-running managers for the offering. Cowen and Company and Leerink Swann &...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-05-11)
More Articles from Health Business Week
- 3D Systems Corporation
3D Systems Recruits Chief Financial Officer - AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ABB
ABB Announces PAT Solution for the Life Sciences Industry - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Aceto Corporation
Aceto Schedules Third Quarter Financial Results News Release and Conference Call - Acne Vulgaris
Acne Sufferers Trading Off Youthful Skin for Treating Acne - Two Linked Conditions - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
